Biosimilar-to-Biosimilar Switches Deemed Safe, Effective
Switching from one biosimilar medication to another is safe and effective, a new systematic review indicates, even though this clinical ...
Switching from one biosimilar medication to another is safe and effective, a new systematic review indicates, even though this clinical ...
Dupilumab dose reduction appears feasible in patients with controlled atopic dermatitis (AD) who have been on the monoclonal antibody therapy ...
BioNTech expects to begin deliveries of two Omicron-adapted vaccines as soon as October. The German biotech firm, which makes the ...
The combination of a tyrosine kinase inhibitor with an immune checkpoint inhibitor significantly improved progression-free survival in patients with hepatocellular carcinoma, ...
Most vaccines don't come as one-shot deals. You need a series of boosters to optimize your immunity to COVID-19, tetanus, ...
New research offers more evidence linking targeted therapies for patients with advanced renal cell carcinoma to higher risks for major ...
INDIANAPOLIS – An investigational topical treatment for dystrophic epidermolysis bullosa (DEB) known as beremagene geperpavec (B-VEC) showed durable and statistically ...
© 2022 Medical News Hubb All rights reserved.
Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy.
© 2022 Medical News Hubb All rights reserved.